|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
vBchtCXhHAtRHdmH |
|
ÀÌ ¸§ |
Lionel |
³¯ Â¥ |
2018/06/29 |
Á¶ ȸ |
5 |
|
I'm from England e2med.com Copaxone accounts for about 20 percent of sales and some 50percent of Teva's profit. Global sales of the drug grew 9percent to $1.1 billion in the second quarter including a riseof 17 percent to $817 million in the United States.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|